肝脏小血管瘤患者MRI动态增强和弥散成像表现特征*

doi:10.3969/j.issn.1672-5069.2024.01.029

摘要/Abstract

摘要： 目的分析肝脏血管瘤(HH)病灶MRI动态增强和弥散成像表现特征。方法 2022年1月～2023年3月我院诊断的肿瘤直径≤2 cm的HH患者113例,所有患者接受肝脏MRI动态增强和弥散成像扫描,分析MRI动态增强和弥散成像表现,记录表观弥散系数(ADC)及最大上升斜率(MSI)、正性增强积分(PEI)和平均强化时间(MET)。结果在113例肝脏小血管瘤患者中发现158个病灶,单发病灶占78.8%,病灶大小为(1.7±0.4)cm;根据动态增强扫描曲线类型分布,发现Ⅰ型病灶27个,Ⅱ型病灶29个,Ⅲ型病灶102个;肝脏左叶病灶71个,右叶病灶87个;肝脏小血管瘤动脉期和门静脉期强化不明显,与肝实质相比总体呈持续相对低信号,延迟期呈轻微高信号,表现为轻中度延迟强化为主;MRI动态增强扫描结果发现,肝脏小血管瘤病灶MSI、PEI和MET分别为(321.0±33.6)、(256.6±30.7) 和(535.9±61.3)s;MRI弥散成像扫描结果发现,肝脏小血管瘤病灶ADC值为(2.4±0.4)×10^-3mm²/s。结论 MRI动态增强和弥散成像对肝脏小血管瘤有较大的诊断价值,可作为临床诊断的重要参考依据。

关键词: 肝脏小血管瘤, MRI动态增强扫描, 弥散成像, 表现特征, 诊断

Abstract: Objective The aim of this study was to summarize the feature of MRI dynamic enhancement and diffusion weighted imaging in patients with small hepatic hemangioma (sHH). Methods A total of 113 patients with ≤2 cm sHH were enrolled in the hospital between January 2022 and March 2023, and all underwent MRI dynamic enhancement and diffusion weighted imaging (DWI) scans. The feature of MRI dynamic enhancement and DWI were summarized. The apparent diffusion coefficient (ADC), maximum slop of increase (MSI), positive enhancement integral (PEI) and mean time to enhancement (MET) were recorded. Results Out of the 113 patients with sHH, 158 lesions were found by MRI scan, and the proportion of single lesions accounted for 78.8%; the lesion size were (1.7±0.4) cm; according to the distribution of curve types by dynamic contrast enhancement, there were 27 lesions of type I, 29 lesions of type II and 102 lesions of type III; there were 71 lesions in the left lobe and 87 lesions in the right lobe; on dynamic contrast-enhanced MRI, sHH were not significantly enhanced at arterial phase and portal venous phase; compared with liver parenchyma, the lesions generally showed continuous relatively low signal, and slight high signal in delayed phase, presenting with mainly mild to moderate delayed enhancement; the MRI dynamic enhancement scan showed that the MSI, PEI and MET in patients with sHH were(321.0±33.6), (256.6±30.7) and (535.9±61.3)s; the DWI scan showed that ADC in patients with sHH was (2.4±0.4) ×10^-3mm²/s. Conclusion The dynamic contrast-enhanced MRI and DWI scan could provide an important tool for clinical diagnosis of patients with sHH.

Key words: Hepatic hemangioma, MRI dynamic enhancement scan, Diffusion weighted imaging, Feature, Diagnosis

贾素兰, 卢昊宁, 杜静波. 肝脏小血管瘤患者MRI动态增强和弥散成像表现特征^*[J]. 实用肝脏病杂志, 2024, 27(1): 113-116.

Jia Sulan, Lu Haoning, Du Jingbo. Feature of MRI dynamic enhancement and diffusion weighted imaging in patients with small hepatic hemangioma[J]. Journal of Practical Hepatology, 2024, 27(1): 113-116.

参考文献

[1] Tanigawa K, Kawano H, Hayashi T, et al. Cardiac angiosarcoma and hepatic hemangioma. Circ J, 2021,85(3):318-326.
[2] Maruyama S, Matono T, Koda M. Prevalence andcharacteristics of hepatic hemangioma associated with coagulopathy and its predictive risk factors. J Clin Med, 2022,11(15):4347-4253.
[3] Leon M, Chavez L, Surani S. Hepatic hemangioma: What internists need to know. World J Gastroenterol, 2020,26(1):11-20.
[4] Mamone G, Di Piazza A, Carollo V, et al. Imaging of hepatic hemangioma: from A to Z. Abdom Radiol (NY), 2020,45(3):672-691.
[5] Imamura H, Hata J. A sonographic software program,fluctuational imaging, for diagnosis of hepatic hemangioma. Sci Rep, 2022,12(1):4701-4706.
[6] Cieszanowski A, Anysz-Grodzicka A, Podgorska J, et al. Magnetic resonance imaging of uncommon hepatic mesenchymal tumours: Haemangioendothelioma and angiosarcoma. Curr Med Imaging Rev, 2019,15(4):362-368.
[7] Soker G, Leblebisatan S, Dilek O, et al. Magnetic resonance imaging evaluation of incidentally detected hyperechoic liver lesions: comparison of two modalities in terms of detection, diagnosis, and morphological features. Rev Assoc Med Bras (1992), 2021,67(12):1839-1845.
[8] 国际肝胆胰协会中国分会HH专业委员会. 肝血管瘤诊断和治疗多学科专家共识(2019年版). 中华消化外科杂志,2019,18(8):705-710.
[9] Bouknani N, Rami A, Kassimi M, et al. Exophytic hepatic hemangioma: a case report. Radiol Case Rep, 2022,17(9):3367-3369.
[10] Fard N, Schlemmer HP, Raue F, et al. CT- and ultrasound-characteristics of hepatic lesions in patients with multiple endocrine neoplasia syndrome. A retrospective image review of 25 cases. PLoS One, 2019,14(2):212865-212871.
[11] Onishi Y, Kusumoto M, Motoi N, et al. Natural history of epithelioid hemangioendothelioma of the liver: CT findings of 15 cases. Acad Radiol, 2021,28(6):778-782.
[12] Wang X, Liang P, Lyu P, et al. Clinical characteristics and CT features of hepatic epithelioid haemangioendothelioma and comparison with those of liver metastases. Insights Imaging, 2022,13(1):9-17.
[13] Lazăr DC, Avram MF, Romo an I, et al. Malignant hepatic vascular tumors in adults: Characteristics, diagnostic difficulties and current management. World J Clin Oncol, 2019,10(3):110-135.
[14] Somers N, Creytens D, Van Belle S, et al. Diagnosis of epithelioid hemangioendothelioma eight days postpartum: Is there a link with pregnancy? A case report and review of the literature. Acta Clin Belg, 2022,77(1):157-162.
[15] Wang A, Chen H, Huang Z, et al. Spontaneous internal hemorrhage of a giant hepatic hemangioma with infection: a case report and literature review. J Int Med Res, 2020,48(12):6474-6481.
[16] Hwang JA, Kang TW, Cha DI, et al. Differentiation of hepatic sclerosed hemangiomas from cavernous hemangiomas based on gadoxetic acid-enhanced magnetic resonance imaging features. J Comput Assist Tomogr, 2019,43(5):762-769.
[17] Jia C, Liu G, Wang X, et al. Hepatic sclerosed hemangioma and sclerosing cavernous hemangioma: a radiological study. Jpn J Radiol, 2021,39(11):1059-1068.
[18] Shin N, Choi JA, Choi JM, et al. Sclerotic changes of cavernous hemangioma in the cirrhotic liver: long-term follow-up using dynamic contrast-enhanced computed tomography. Radiol Med, 2020,125(12):1225-1232.
[19] Garza A, Elsherif SB, Faria SC, et al. Staging MRI of uterine malignant mixed Müllerian tumors versus endometrial carcinomas with emphasis on dynamic enhancement characteristics. Abdom Radiol (NY), 2020,45(4):1141-1154.
[20] Chen J, Si Y, Zhao K, et al. Evaluation of quantitative parameters of dynamic contrast-enhanced magnetic resonance imaging in qualitative diagnosis of hepatic masses. BMC Med Imaging, 2018,18(1):56-62.
[21] Tokgoz O, Unlu E, Unal I, et al. Diagnostic value of diffusion weighted MRI and ADC in differential diagnosis of cavernous hemangioma of the liver. Afr Health Sci,2016,16(1):227-233.
[22] Xie S, Li Q, Cheng Y, et al. Differentiating mild and substantial hepatic fibrosis from healthy controls: a comparison of diffusion kurtosis imaging and conventional diffusion-weighted imaging. Acta Radiol, 2020,61(8):1012-1020.
[23] Abu Ata N, Dillman JR, Gandhi DB, et al. Association between liver diffusion-weighted imaging apparent diffusion coefficient values and other measures of liver disease in pediatric autoimmune liver disease patients. Abdom Radiol (NY), 2021,46(1):197-204.
[24] Surov A, Pech M, Omari J, et al. Diffusion-weighted imaging reflects tumor grading and microvascular invasion in hepatocellular carcinoma. Liver Cancer, 2021,10(1):10-24.
[25] Gultekin MA, Turk HM, Yurtsever I, et al. Apparent diffusion coefficient values for neuroendocrine liver metastases. Acad Radiol, 2021,28(1):81-86.
[26] Jia Y, Cai H, Wang M, et al. Diffusion kurtosisMR imaging versus conventional diffusion-weighted imaging for distinguishing hepatocellular carcinoma from benign hepatic nodules. Contrast Media Mol Imaging, 2019,19(1):2030147.

肝脏小血管瘤患者MRI动态增强和弥散成像表现特征^*

Feature of MRI dynamic enhancement and diffusion weighted imaging in patients with small hepatic hemangioma

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	诸葛宇征. 重视内脏静脉血栓形成的诊断和管理^*[J]. 实用肝脏病杂志, 2024, 27(1): 1-2.
[2]	鲁文婷, 张峰. 非肝硬化门静脉系统血栓形成临床管理[J]. 实用肝脏病杂志, 2024, 27(1): 7-10.
[3]	李凯, 石波, 程序, 赵凯. 应用STE/STQ技术评估慢性乙型肝炎患者肝纤维化程度效能研究^*[J]. 实用肝脏病杂志, 2024, 27(1): 20-23.
[4]	叶茜, 郑东, 杨昕宇, 郭江, 符美茵, 谢燕华, 刘洪. 超声衰减参数联合血清PAI-1和ALT水平评估代谢相关脂肪性肝病患者肝脂肪变性程度的价值分析^*[J]. 实用肝脏病杂志, 2024, 27(1): 44-47.
[5]	张书琴, 王婷婷, 张艳红. 实时组织弹性成像评估非酒精性脂肪性肝炎患者肝纤维化分期临床价值研究^*[J]. 实用肝脏病杂志, 2024, 27(1): 48-51.
[6]	杨晶, 陈美玲, 张丽秀, 颜鲁伟, 白正强, 贺锐. 慢加急性乙型肝炎肝衰竭患者细菌感染病原菌分布及血清PCT、IFN-γ和IL-6水平变化分析^*[J]. 实用肝脏病杂志, 2024, 27(1): 64-67.
[7]	穆玉娟, 吴斐斐, 陈莹. 磁共振增强T1 mapping和IVIM-DWI技术评估乙型肝炎肝硬化患者肝脏储备功能价值研究^*[J]. 实用肝脏病杂志, 2024, 27(1): 68-71.
[8]	宋一凡, 郑帅, 许芸, 唐铁骑. 超声半定量评分结合瞬时弹性成像技术评估乙型肝炎肝硬化并发食管静脉曲张价值研究^*[J]. 实用肝脏病杂志, 2024, 27(1): 72-75.
[9]	郝永欣, 孟祥安, 骆允, 高美丽, 刘欢, 刘磊, 沈荣. 超声造影与增强CT检查诊断小肝癌效能比较^*[J]. 实用肝脏病杂志, 2024, 27(1): 88-91.
[10]	丁建华, 张波, 邓国莉. CT和MRI动态增强扫描诊断和评估原发性肝癌患者微血管浸润价值研究[J]. 实用肝脏病杂志, 2024, 27(1): 109-112.
[11]	肖琨, 刘爱华, 刘琨. 彩色多普勒超声与磁共振胰胆管成像诊断胆囊结石价值比较^*[J]. 实用肝脏病杂志, 2024, 27(1): 137-140.
[12]	邵孝如, 周筱, 葛颖颖. ¹⁸F-FDG摄取量诊断非酒精性脂肪性肝病患者罹患冠状动脉粥样硬化性心脏病探讨^*[J]. 实用肝脏病杂志, 2023, 26(6): 811-814.
[13]	丁晓洁, 张永明, 宋海燕, 王文平, 宋洁, 撒小军, 邹永红. 2型糖尿病合并非酒精性脂肪性肝病患者NLR和PLR变化及其临床意义探讨^*[J]. 实用肝脏病杂志, 2023, 26(6): 815-818.
[14]	阎道博, 朱海超, 闪海霞. 瞬时弹性成像联合APRI诊断自身免疫性肝炎患者肝纤维化效能研究^*[J]. 实用肝脏病杂志, 2023, 26(6): 831-834.
[15]	田宇, 陈燕, 曹佳非, 周晓倩. 肝硬化并发肝肾综合征患者U-mAl及外周血NLR和血清NGAL水平变化研究^*[J]. 实用肝脏病杂志, 2023, 26(6): 859-862.